Indeed, ADP-ribosylation has a role in β-cell death; in murine islets, PARP1 induces cytokine-mediated β-cell death, and its deletion protects against streptozotocin-mediated diabetes [35, 56, 57]. Here, PARP1 is linked to diabetes mellitus.